169 related articles for article (PubMed ID: 23644215)
1. Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.
Das S; Das U; Michel D; Gorecki DK; Dimmock JR
Eur J Med Chem; 2013 Jun; 64():321-8. PubMed ID: 23644215
[TBL] [Abstract][Full Text] [Related]
2. Dimeric 3,5-bis(benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties.
Das S; Das U; Sakagami H; Umemura N; Iwamoto S; Matsuta T; Kawase M; Molnár J; Serly J; Gorecki DK; Dimmock JR
Eur J Med Chem; 2012 May; 51():193-9. PubMed ID: 22409967
[TBL] [Abstract][Full Text] [Related]
3. 3,5-Bis(3-alkylaminomethyl-4-hydroxybenzylidene)-4-piperidones: A Novel Class of Potent Tumor-Selective Cytotoxins.
Karki SS; Das U; Umemura N; Sakagami H; Iwamoto S; Kawase M; Balzarini J; De Clercq E; Dimmock SG; Dimmock JR
J Med Chem; 2016 Jan; 59(2):763-9. PubMed ID: 26727215
[TBL] [Abstract][Full Text] [Related]
4. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties.
Sun J; Zhang S; Yu C; Hou G; Zhang X; Li K; Zhao F
Chem Biol Drug Des; 2014 Apr; 83(4):392-400. PubMed ID: 24148151
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR
Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of some N-acyl analogues of 3,5-bis(arylidene)-4-piperidones for cytotoxic activity.
Dimmock JR; Arora VK; Duffy MJ; Reid RS; Allen TM; Kao GY
Drug Des Discov; 1992 Jul; 8(4):291-9. PubMed ID: 1445994
[TBL] [Abstract][Full Text] [Related]
8. Novel hybrid molecules of 3,5-bis(benzylidene)-4-piperidones and dichloroacetic acid which demonstrate potent tumour-selective cytotoxicity.
Hossain M; Das S; Das U; Doroudi A; Zhu J; Dimmock JR
Bioorg Med Chem Lett; 2020 Feb; 30(3):126878. PubMed ID: 31864797
[TBL] [Abstract][Full Text] [Related]
9. E,E,E-1-(4-Arylamino-4-oxo-2-butenoyl)-3,5-bis(arylidene)-4-piperidones: a topographical study of some novel potent cytotoxins.
Jha A; Mukherjee C; Prasad AK; Parmar VS; Clercq ED; Balzarini J; Stables JP; Manavathu EK; Shrivastav A; Sharma RK; Nienaber KH; Zello GA; Dimmock JR
Bioorg Med Chem; 2007 Sep; 15(17):5854-65. PubMed ID: 17562365
[TBL] [Abstract][Full Text] [Related]
10. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.
Li N; Xin WY; Yao BR; Wang CH; Cong W; Zhao F; Li HJ; Hou Y; Meng QG; Hou GG
Eur J Med Chem; 2018 Mar; 147():21-33. PubMed ID: 29421568
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines.
Brossard D; Lechevrel M; El Kihel L; Quesnelle C; Khalid M; Moslemi S; Reimund JM
Eur J Med Chem; 2014 Oct; 86():279-90. PubMed ID: 25173827
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity.
Kálai T; Kuppusamy ML; Balog M; Selvendiran K; Rivera BK; Kuppusamy P; Hideg K
J Med Chem; 2011 Aug; 54(15):5414-21. PubMed ID: 21702507
[TBL] [Abstract][Full Text] [Related]
13. Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.
Santiago-Vazquez Y; Das S; Das U; Robles-Escajeda E; Ortega NM; Lema C; Varela-Ramírez A; Aguilera RJ; Balzarini J; De Clercq E; Dimmock SG; Gorecki DK; Dimmock JR
Eur J Med Chem; 2014 Apr; 77():315-22. PubMed ID: 24657568
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and potent antileukemic activities of 10-benzyl-9(10H)-acridinones.
Gao C; Jiang Y; Tan C; Zu X; Liu H; Cao D
Bioorg Med Chem; 2008 Sep; 16(18):8670-5. PubMed ID: 18713666
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new podophyllic aldehyde derivatives with cytotoxic and apoptosis-inducing activities.
Castro MA; del Corral JM; García PA; Rojo MV; de la Iglesia-Vicente J; Mollinedo F; Cuevas C; San Feliciano A
J Med Chem; 2010 Feb; 53(3):983-93. PubMed ID: 20067289
[TBL] [Abstract][Full Text] [Related]
16. Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones.
Hossain M; Das U; Umemura N; Sakagami H; Balzarini J; De Clercq E; Kawase M; Dimmock JR
Bioorg Med Chem; 2016 May; 24(10):2206-14. PubMed ID: 27073056
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer, and antibacterial activities of piplartine derivatives on cell cycle regulation and growth inhibition.
Kumar JU; Shankaraiah G; Kumar RS; Pitke VV; Rao GT; Poornima B; Babu KS; Sreedhar AS
J Asian Nat Prod Res; 2013; 15(6):658-69. PubMed ID: 23668860
[TBL] [Abstract][Full Text] [Related]
18. Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity.
Schmitt F; Subramaniam D; Anant S; Padhye S; Begemann G; Schobert R; Biersack B
ChemMedChem; 2018 Jun; 13(11):1115-1123. PubMed ID: 29570947
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cells.
Helal M; Das U; Bandy B; Islam A; Nazarali AJ; Dimmock JR
Bioorg Med Chem Lett; 2013 Feb; 23(4):1075-8. PubMed ID: 23305919
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative Effect of a Novel 4,4'-Disulfonyldiarylidenyl Piperidone in Human Colon Cancer Cells.
Prabhat AM; Kuppusamy ML; Bognár B; Kálai T; Hideg K; Kuppusamy P
Cell Biochem Biophys; 2019 Mar; 77(1):61-67. PubMed ID: 30552554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
